The RWG is made up of representatives from MAP developers, regulatory authorities, and public health organisations including PATH, The Bill and Melinda Gates Foundation, World Health Organisation (WHO), British Pharmacopoeia (BP), US Food and Drug Administration (FDA), United States Pharmacopoeia, Gachon University, Georgia Tech, Queens University Belfast, Allergan, Corium, Kindeva, LTS, Micron Biomedical, Radius Health Inc, Raphas, Vaxxas, Zosano and Cardiff University.
However, the project is a shared endeavour and it is important to ensure that all stakeholders have an opportunity to contribute to the work. Therefore we are preparing an online tool that will enable you to provide your opinions on the nomenclature and definition of the 'MAP' dosage form, considerations when determining their critical quality attributes (CQAs) and accompanying standardised testing methods.
Watch this space......and to save you the trouble of regularly checking the website for updates then simply register your interest here.
However, the project is a shared endeavour and it is important to ensure that all stakeholders have an opportunity to contribute to the work. Therefore we are preparing an online tool that will enable you to provide your opinions on the nomenclature and definition of the 'MAP' dosage form, considerations when determining their critical quality attributes (CQAs) and accompanying standardised testing methods.
Watch this space......and to save you the trouble of regularly checking the website for updates then simply register your interest here.
